HNGE
Hinge Health, Inc.
NYSEUSDEQUITY
Healthcare
DELAYED
Strong buy
+62/100
Last price
98.35
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
98.35
Day high
100.36
Day low
96.02
Volume
2.91M
Market cap
$7.94B
P/E (TTM)
32.46
52W range
30.08 – 100.36
Trailing performance
Returnvs SPY
1W
+3.30%
+1.3%
1M
+6.47%
+5.3%
3M
+11.13%
+6.6%
6M
+158.68%
+140.5%
YTD
+111.73%
+97.5%
1Y
+91.75%
+75.3%
3Y
—
-82.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on HNGE open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-320.08K
Net selling
Buy transactions
21
4.79M shares
Sell transactions
32
5.11M shares
Net transactions
+53
Buys less sells
Sell : buy shares
1.1 : 1
Mixed
Insider-held shares
3.89M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Oct 5, 26 | SLOAT TYLER Director |
STOCK | 175 | $16.20K | Direct |
| Sep 21, 26 | PURSLEY JAMES President |
SELL | 33.00K | $3.11M | Direct |
| Sep 14, 26 | MECKLENBURG GABRIEL M.I. Director |
SELL | 150.00K | $13.98M | Direct |
| Sep 14, 26 | ROBINSON ELLIOTT Director |
SELL | 147.94K | $13.84M | Indirect |
| Sep 14, 26 | MECKLENBURG GABRIEL M.I. Director |
— | 150.00K | — | Direct |
| Sep 11, 26 | MECKLENBURG GABRIEL M.I. Director |
SELL | 250.00K | $22.24M | Direct |
| Sep 11, 26 | MECKLENBURG GABRIEL M.I. Director |
— | 250.00K | — | Direct |
| Sep 10, 26 | PEREZ DANIEL ANTONIO Chief Executive Officer |
STOCK | 45.00K | $0 | Direct |
| Sep 10, 26 | BUDGE JAMES W. Chief Financial Officer |
SELL | 55.56K | $4.97M | Direct |
| Sep 10, 26 | PEREZ DANIEL ANTONIO Chief Executive Officer |
SELL | 250.00K | $22.36M | |
| Sep 10, 26 | PEREZ DANIEL ANTONIO Chief Executive Officer |
— | 295.00K | — | |
| Sep 9, 26 | ROBINSON ELLIOTT Director |
SELL | 11.34K | $1.05M | Indirect |
| Sep 8, 26 | ROBINSON ELLIOTT Director |
SELL | 55.17K | $5.10M | Indirect |
| Sep 3, 26 | ROBINSON ELLIOTT Director |
SELL | 70.64K | $6.57M | Indirect |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
11.2 CAPITAL I PARTNERS, LLC |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
ATOMICO ADVISORS IV, LTD |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
BESSEMER VENTURE PARTNERS X L.P. |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
BUDGE JAMES W. |
Chief Financial Officer | 349.06K | Sale |
INSIGHT HOLDINGS GROUP, L.L.C. |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
LESLIE KRISTINA M |
Director | 30.39K | Sale |
MECKLENBURG GABRIEL M.I. |
Director | 0 | Sale |
PEREZ DANIEL ANTONIO |
Chief Executive Officer | 35.47K | Stock Gift |
PURSLEY JAMES |
President | 666.91K | Sale |
SLOAT TYLER |
Director | 10.38K | Stock Award(Grant) |
Fundamentals
Market cap$7.94B
Enterprise value$7.55B
Revenue (TTM)$720.06M
Gross profit$608.75M
EBITDA$95.69M
Net income$107.28M
EPS (TTM)$3.03
Free cash flow$299.65M
Total cash$389.39M
Total debt$5.88M
Book value / share$4.29
Shares outstanding62.47M
Float50.37M
Short % of float7.83%
Dividend yield0.00%
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E32.46
Forward P/E32.17
PEG ratio—
Price / sales—
Price / book22.91
EV / revenue10.49
EV / EBITDA78.93
Gross margin84.54%
Operating margin19.00%
Profit margin15.15%
Return on equity30.38%
Return on assets7.70%
Debt / equity1.71
Current ratio1.34
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|
| Total revenue | $587.86M | $390.40M | $292.73M | +50.6% |
| Operating revenue | $587.86M | $390.40M | $292.73M | +50.6% |
| Cost of revenue | $119.64M | $90.50M | $98.55M | +32.2% |
| Gross profit | $468.22M | $299.90M | $194.18M | +56.1% |
| Research & development | $368.14M | $100.84M | $110.06M | +265.1% |
| Selling, general & admin | $646.46M | $230.97M | $214.63M | +179.9% |
| Total operating expense | $1.01B | $331.81M | $324.69M | +205.8% |
| Operating income | -$546.37M | -$31.91M | -$130.51M | -1,612.2% |
| Pre-tax income | -$527.26M | -$11.26M | -$108.55M | -4,584.3% |
| Tax provision | $998.00K | $677.00K | -$405.00K | +47.4% |
| Net income | -$528.26M | -$11.93M | -$108.14M | -4,326.9% |
| Net income to common | -$424.09M | -$11.93M | -$108.14M | -3,453.9% |
| Basic EPS | -7.77 | -0.15 | -1.58 | -4,979.9% |
| Diluted EPS | -7.77 | -0.15 | -1.58 | -4,979.9% |
| EBIT | -$546.37M | -$31.91M | -$130.51M | -1,612.2% |
| EBITDA | -$541.24M | -$25.96M | -$124.89M | -1,984.9% |
| Basic shares | 54.58M | 78.02M | 68.54M | -30.0% |
| Diluted shares | 54.58M | 78.02M | 91.90M | -30.0% |
| Line item | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $208.00M | $300.79M | $234.95M | -30.8% |
| Cash & short-term investments | $363.86M | $466.57M | $423.36M | -22.0% |
| Accounts receivable | $51.04M | $37.66M | $29.75M | +35.5% |
| Inventory | $15.64M | $10.87M | $13.29M | +43.8% |
| Total current assets | $533.90M | $583.45M | $529.88M | -8.5% |
| Property, plant & equipment | $17.35M | $16.99M | $22.48M | +2.1% |
| Goodwill & intangibles | $66.61M | $63.41M | $63.79M | +5.0% |
| Total assets | $744.76M | $673.26M | $622.53M | +10.6% |
| Total current liabilities | $362.41M | $249.30M | $184.16M | +45.4% |
| Total debt | $8.04M | $11.07M | $15.73M | -27.4% |
| Total liabilities | $366.23M | $256.56M | $195.25M | +42.7% |
| Retained earnings | -$1.05B | -$522.74M | -$510.80M | -101.1% |
| Shareholder equity | $378.54M | $416.70M | $427.28M | -9.2% |
| Working capital | $171.50M | $334.15M | $345.73M | -48.7% |
| Net tangible assets | $311.93M | $353.29M | $363.49M | -11.7% |
| Shares issued | 79.17M | 78.02M | 78.02M | +1.5% |
| Line item | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|
| Net income | -$528.26M | -$11.93M | -$108.14M | -4,326.9% |
| Depreciation & amortisation | $5.13M | $5.95M | $5.63M | -13.7% |
| Stock-based compensation | $643.01M | $739.00K | $1.65M | +86,910.7% |
| Change in working capital | -$2.01M | $13.50M | $9.41M | -114.9% |
| Operating cash flow | $171.44M | $49.00M | -$63.91M | +249.9% |
| Capital expenditure | -$6.06M | -$3.77M | -$4.62M | -60.7% |
| Investing cash flow | -$113.76M | $18.31M | $1.50M | -721.2% |
| Share buybacks | -$65.03M | $0 | $0 | — |
| Financing cash flow | -$150.47M | -$2.20M | -$3.00M | -6,733.2% |
| Free cash flow | $165.38M | $45.23M | -$68.52M | +265.6% |
| End cash position | $209.80M | $302.59M | $237.47M | -30.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $212.82M | $182.31M | $170.73M | $154.21M | $139.10M | +16.7% |
| Operating revenue | $212.82M | $182.31M | $170.73M | $154.21M | $139.10M | +16.7% |
| Cost of revenue | $28.87M | $28.07M | $26.70M | $28.01M | $41.34M | +2.8% |
| Gross profit | $183.95M | $154.23M | $144.03M | $126.20M | $97.76M | +19.3% |
| Research & development | $34.06M | $30.34M | $32.76M | $31.92M | $279.96M | +12.3% |
| Selling, general & admin | $109.45M | $91.83M | $84.02M | $100.37M | $398.47M | +19.2% |
| Total operating expense | $143.51M | $122.16M | $116.77M | $132.29M | $678.43M | +17.5% |
| Operating income | $40.44M | $32.07M | $27.26M | -$6.09M | -$580.67M | +26.1% |
| Pre-tax income | $44.43M | $35.94M | $32.22M | -$1.64M | -$575.98M | +23.6% |
| Tax provision | $740.00K | $814.00K | $122.00K | $206.00K | -$326.00K | -9.1% |
| Net income | $43.69M | $35.13M | $32.09M | -$1.84M | -$575.65M | +24.4% |
| Net income to common | $43.10M | $34.01M | $32.09M | -$1.84M | -$575.65M | +26.7% |
| Basic EPS | 0.55 | 0.43 | 0.39 | -0.02 | -13.10 | +27.9% |
| Diluted EPS | 0.52 | 0.41 | 0.37 | -0.02 | -13.10 | +26.8% |
| EBIT | $40.44M | $32.07M | $27.26M | -$6.09M | -$580.67M | +26.1% |
| EBITDA | $41.50M | $33.24M | $28.48M | -$4.83M | -$579.33M | +24.8% |
| Basic shares | 78.97M | 78.62M | 79.52M | 78.86M | 43.93M | +0.4% |
| Diluted shares | 83.42M | 82.39M | 84.53M | 78.86M | 43.93M | +1.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $286.22M | $186.67M | $208.00M | $261.34M | $237.17M | +53.3% |
| Cash & short-term investments | $389.39M | $315.87M | $363.86M | $480.03M | $413.26M | +23.3% |
| Accounts receivable | $91.79M | $69.60M | $51.04M | $59.98M | $69.83M | +31.9% |
| Inventory | $16.77M | $14.17M | $15.64M | $13.81M | $13.99M | +18.4% |
| Total current assets | $643.35M | $540.05M | $533.90M | $658.88M | $598.42M | +19.1% |
| Property, plant & equipment | $17.77M | $17.31M | $17.35M | $16.14M | $16.33M | +2.7% |
| Goodwill & intangibles | $66.16M | $66.38M | $66.61M | $66.83M | $67.06M | -0.3% |
| Total assets | $827.40M | $728.77M | $744.76M | $769.80M | $693.65M | +13.5% |
| Total current liabilities | $481.44M | $414.48M | $362.41M | $357.08M | $314.08M | +16.2% |
| Total debt | $5.88M | $6.97M | $8.04M | $9.03M | $9.97M | -15.6% |
| Total liabilities | $483.07M | $417.21M | $366.23M | $361.93M | $320.00M | +15.8% |
| Retained earnings | -$972.18M | -$1.02B | -$1.05B | -$1.08B | -$1.08B | +4.3% |
| Shareholder equity | $344.33M | $311.56M | $378.54M | $407.87M | $373.65M | +10.5% |
| Working capital | $161.91M | $125.58M | $171.50M | $301.81M | $284.34M | +28.9% |
| Net tangible assets | $278.17M | $245.18M | $311.93M | $341.04M | $306.60M | +13.5% |
| Shares issued | 80.20M | 77.30M | 79.17M | 78.72M | 78.13M | +3.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $43.69M | $35.13M | $32.09M | -$1.84M | -$575.65M | — | +24.4% |
| Depreciation & amortisation | $1.06M | $1.17M | $1.22M | $1.26M | $1.34M | — | -9.5% |
| Stock-based compensation | $19.09M | $11.69M | $17.17M | $34.85M | $590.98M | — | +63.3% |
| Change in working capital | $15.36M | -$22.16M | -$1.32M | $34.04M | -$10.23M | — | +169.3% |
| Operating cash flow | $101.41M | $43.08M | $63.89M | $82.40M | $20.23M | — | +135.4% |
| Capital expenditure | -$1.85M | -$1.53M | -$2.36M | -$1.12M | -$1.83M | — | -21.2% |
| Investing cash flow | $28.62M | $48.08M | -$37.70M | -$58.76M | $4.02M | — | -40.5% |
| Share buybacks | -$26.52M | -$104.97M | — | — | $0 | $0 | +74.7% |
| Financing cash flow | -$30.48M | -$112.85M | -$79.55M | $531.00K | -$75.56M | — | +73.0% |
| Free cash flow | $99.56M | $41.55M | $61.53M | $81.28M | $18.40M | — | +139.6% |
| End cash position | $287.67M | $188.11M | $209.80M | $263.14M | $238.97M | — | +52.9% |
Options analytics
Put / call volume
0.05
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
45.00
-54.2% from spot
ATM implied vol
3.1%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
1.92K
Contracts, this expiry
Put volume
100
Contracts, this expiry
Heaviest call OI
45.00
0 contracts
Heaviest put OI
60.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.62 | 0.59 | -4.1% |
| Mar 2026 | 0.40 | 0.45 | +13.3% |
| Dec 2025 | 0.43 | 0.49 | +15.2% |
| Sep 2025 | 0.24 | 0.44 | +81.6% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.60 | 13 | $224.71M | +45.7% |
| Next quarter | 0.66 | 13 | $239.49M | +40.3% |
| Current year | 2.40 | 14 | $860.41M | +46.4% |
| Next year | 3.06 | 13 | $1.09B | +26.4% |
Analyst targets & ownership
Mean target$110.56
High target$140.00
Low target$90.00
Implied upside12.42%
Analyst count16
ConsensusBUY
Strong buy / Buy7 / 9
Hold1
Sell / Strong sell0 / 0
Held by insiders4.82%
Held by institutions95.61%
Institutions holding372
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
95.70
+2.76% from price
SMA 20
94.22
+4.39% from price
SMA 50
89.46
+9.94% from price
SMA 100
80.27
+22.53% from price
SMA 200
61.66
+59.51% from price
EMA 12
95.99
+2.46% from price
EMA 26
93.68
+4.99% from price
EMA 50
89.60
+9.77% from price
RSI (14)
62.1
Neutral
MACD (12,26,9)
2.31
Hist 0.23
ATR (14)
3.67
3.74% of price
Realised vol 30D
41.5%
Annualised
Bollinger upper
99.94
20, 2σ
Bollinger lower
88.49
20, 2σ
50 / 200 cross
Golden
89.46 vs 61.66
Trend bias
Above 200
+59.51%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.03
More volatile than market
Correlation to SPY
0.25
Largely independent
Realised vol 30D
41.5%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-42.1%
Peak to trough
Max drawdown 5Y
-48.5%
Peak to trough
ATR 14
3.67
3.74% of price
Beta (reported)
—
5Y monthly, from filing
Short interest
Shares short
4.83M
Prior 5.63M
Change vs prior
-14.2%
Shorts covering
% of float
7.83%
Normal
% of shares out
5.99%
Against total outstanding
Days to cover
2.6
Liquid
Float
50.37M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 30, 26 | Needham | MAINTAINED | Buy | Buy |
| Sep 22, 26 | Baird | MAINTAINED | Neutral | Neutral |
| Sep 8, 26 | Stifel | MAINTAINED | Buy | Buy |
| Aug 11, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Aug 5, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Aug 5, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| Aug 5, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Aug 5, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| Aug 5, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Aug 5, 26 | Needham | MAINTAINED | Buy | Buy |
| Jul 27, 26 | Stifel | MAINTAINED | Buy | Buy |
| Jul 27, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-21
Periodic Financial Reports
10-Q · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-08-04
Corporate Changes & Voting Matters
8-K · 2026-06-09
Corporate Changes & Voting Matters
8-K · 2026-06-04
Periodic Financial Reports
10-Q · 2026-05-07
Corporate Changes & Voting Matters
8-K · 2026-05-05
Annual Report to Shareholders
ARS · 2026-04-17
Headlines
Hinge Health to announce third quarter 2026 financial results on November 2, 2026
Business Wire · 2d ago
These IBD 50 Stocks Are Stalled. That Could Be A Good Thing.
Investor's Business Daily · 5d ago
The 25-Year Stock Market Supercycle: Why The Biggest Acceleration Phase Is Still Ahead
Investor's Business Daily · 6d ago
Hinge Health Growth Outlook Supported by Member Gains, New Products, BofA Says
MT Newswires · 8d ago
Netflix upgraded, PepsiCo downgraded: Wall Street's top analyst calls
The Fly · 8d ago
Hinge Health Insider Sold Shares Worth $3,106,504, According to a Recent SEC Filing
MT Newswires · 14d ago
Exceptional Earnings and AI Immunity Fuel Hinge Health’s (HNGE) Performance
Insider Monkey · 14d ago
Reasons to Hold Hinge Health Stock in Your Portfolio for Now
Zacks · 16d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.